Interested in discovering how you can protect your study endpoints during COVID-19 and beyond? Click here to learn how Timely, Targeted Interventions can be leveraged for your clinical trial's needs.
Recent Insights
»
Case Studies
»
How a Top 25 Pharma Company Reduced the Placebo Response for their Phase II Study
Most Recent Flipbooks

How A Top-Pharma Client Transformed Its Safety-Reporting Process, Saving $11.2 Million in One Year

Accurate Pain Reporting
WCG Analgesic Solutions found that patients could better report their pain intensity and discriminate between active drug and placebo using accurate pain reporting training.
How a Top Pharma Company Successfully Enrolled for a MDD Study
ThreeWire was able to quickly review charts at the 48 sites, leading to 121 consents and 69 enrolled subjects. These efforts contributed 34.5% of all enrollments.